Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Baidu Inc (BIDU) vs Tilray Brands Inc (TLRY) Price & Performance

Baidu IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Baidu Inc vs Tilray Brands Inc — how do they compare? Baidu Inc trades at $112.63 (market cap $36.80B), while Tilray Brands Inc trades at $4.45 (market cap $540.74M). The key difference: Baidu Inc is far larger — about 68.1× Tilray Brands Inc's market cap, and Baidu Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

BIDUTLRY
Market Cap
$36.80B$540.74M
Sector
MediaHealth
52-Week High
$162.52$21.00
52-Week Low
$85.86$4.31
Enterprise Value
$33.45B$637.89M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Baidu Inc

Baidu (BIDU) trades at $113.39, down 3.52% amid bearish technical signals and mixed fundamentals. The stock faces pressure from declining revenue and net income margins, though it maintains strong analyst support with a $161 consensus price target. Recent news highlights AI optimism from Kunlunxin's potential $50 billion Hong Kong IPO, while cash flow trends show significant investing outflows. Technical indicators show bearish moving averages with neutral oscillators, trading near key support at $112.

Baidu presents a high-risk opportunity with Wall Street maintaining bullish ratings despite recent earnings volatility. The AI pivot and potential chip unit IPO offer growth catalysts, but declining profitability and negative cash flows pose substantial risks. Investors should weigh strong balance sheet strength against execution challenges in China's competitive tech landscape.

Tilray Brands Inc

TLRY trades at $4.46, up 0.9% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, though revenue grew to $821.31 million. Analyst consensus is cautious with 65% hold ratings, and recent news highlights expansion in medical cannabis and new product launches.

The outlook remains challenged by persistent losses and high debt levels, but low valuation ratios like P/S of 0.54 and P/B of 0.35 may attract value investors. Key risks include profitability struggles and regulatory uncertainty, while potential catalysts include international expansion and upcoming earnings on July 28, 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Baidu Inc

Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.

Read more on BIDU

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY